Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.

Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Müller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H.

Nat Genet. 2010 May;42(5):410-4. doi: 10.1038/ng.569.

PMID:
20400964
2.

Germline RAD51C mutations in ovarian cancer susceptibility.

Coulet F, Fajac A, Colas C, Eyries M, Dion-Minière A, Rouzier R, Uzan S, Lefranc JP, Carbonnel M, Cornelis F, Cortez A, Soubrier F.

Clin Genet. 2013 Apr;83(4):332-6. doi: 10.1111/j.1399-0004.2012.01917.x.

PMID:
22725699
3.

Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility.

Vuorela M, Pylkäs K, Hartikainen JM, Sundfeldt K, Lindblom A, von Wachenfeldt Wäppling A, Haanpää M, Puistola U, Rosengren A, Anttila M, Kosma VM, Mannermaa A, Winqvist R.

Breast Cancer Res Treat. 2011 Dec;130(3):1003-10. doi: 10.1007/s10549-011-1677-x.

PMID:
21750962
4.

Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer.

Zheng Y, Zhang J, Hope K, Niu Q, Huo D, Olopade OI.

Breast Cancer Res Treat. 2010 Dec;124(3):857-61. doi: 10.1007/s10549-010-1095-5.

PMID:
20697805
5.

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients.

Thompson ER, Boyle SE, Johnson J, Ryland GL, Sawyer S, Choong DY, kConFab, Chenevix-Trench G, Trainer AH, Lindeman GJ, Mitchell G, James PA, Campbell IG.

Hum Mutat. 2012 Jan;33(1):95-9. doi: 10.1002/humu.21625.

PMID:
21990120
6.

Fanconi anemia and breast cancer susceptibility meet again.

Levy-Lahad E.

Nat Genet. 2010 May;42(5):368-9. doi: 10.1038/ng0510-368.

PMID:
20428093
7.

RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.

Somyajit K, Subramanya S, Nagaraju G.

Carcinogenesis. 2010 Dec;31(12):2031-8. doi: 10.1093/carcin/bgq210. Review.

8.

Germline mutation in the RAD51B gene confers predisposition to breast cancer.

Golmard L, Caux-Moncoutier V, Davy G, Al Ageeli E, Poirot B, Tirapo C, Michaux D, Barbaroux C, d'Enghien CD, Nicolas A, Castéra L, Sastre-Garau X, Stern MH, Houdayer C, Stoppa-Lyonnet D.

BMC Cancer. 2013 Oct 19;13:484. doi: 10.1186/1471-2407-13-484.

9.

RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families.

Blanco A, Gutiérrez-Enríquez S, Santamariña M, Montalban G, Bonache S, Balmaña J, Carracedo A, Diez O, Vega A.

Breast Cancer Res Treat. 2014 Aug;147(1):133-43. doi: 10.1007/s10549-014-3078-4.

PMID:
25086635
10.

RAD51C is a susceptibility gene for ovarian cancer.

Pelttari LM, Heikkinen T, Thompson D, Kallioniemi A, Schleutker J, Holli K, Blomqvist C, Aittomäki K, Bützow R, Nevanlinna H.

Hum Mol Genet. 2011 Aug 15;20(16):3278-88. doi: 10.1093/hmg/ddr229.

11.

Germline mutations in RAD51C in Jewish high cancer risk families.

Kushnir A, Laitman Y, Shimon SP, Berger R, Friedman E.

Breast Cancer Res Treat. 2012 Dec;136(3):869-74. doi: 10.1007/s10549-012-2317-9.

PMID:
23117857
12.

Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan.

Rashid MU, Muhammad N, Faisal S, Amin A, Hamann U.

Breast Cancer Res Treat. 2014 Jun;145(3):775-84. doi: 10.1007/s10549-014-2972-0.

PMID:
24800917
13.

Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.

Somyajit K, Subramanya S, Nagaraju G.

J Biol Chem. 2012 Jan 27;287(5):3366-80. doi: 10.1074/jbc.M111.311241.

14.

German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene.

Hamann U, Brauch H, Garvin AM, Bastert G, Scott RJ.

Genes Chromosomes Cancer. 1997 Feb;18(2):126-32.

PMID:
9115962
15.

Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer families.

Hamann U, Häner M, Stosiek U, Bastert G, Scott RJ.

J Med Genet. 1997 Nov;34(11):884-8.

16.

Rad52 gene mutations in breast/ovarian cancer families and sporadic ovarian carcinoma patients.

Tong D, Volm T, Eberhardt E, Krainer M, Leodolter S, Kreienberg R, Zeillinger R.

Oncol Rep. 2003 Sep-Oct;10(5):1551-3.

PMID:
12883740
17.

Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.

Seal S, Barfoot R, Jayatilake H, Smith P, Renwick A, Bascombe L, McGuffog L, Evans DG, Eccles D, Easton DF, Stratton MR, Rahman N; Breast Cancer Susceptibility Collaboration..

Cancer Res. 2003 Dec 15;63(24):8596-9.

18.

Mutation of the RAD51C gene in a Fanconi anemia-like disorder.

Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, Neveling K, Endt D, Kesterton I, Autore F, Fraternali F, Freund M, Hartmann L, Grimwade D, Roberts RG, Schaal H, Mohammed S, Rahman N, Schindler D, Mathew CG.

Nat Genet. 2010 May;42(5):406-9. doi: 10.1038/ng.570.

PMID:
20400963
19.

Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.

Johannsson O, Ostermeyer EA, Håkansson S, Friedman LS, Johansson U, Sellberg G, Brøndum-Nielsen K, Sele V, Olsson H, King MC, Borg A.

Am J Hum Genet. 1996 Mar;58(3):441-50.

20.

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families.

Romero A, Pérez-Segura P, Tosar A, García-Saenz JA, Díaz-Rubio E, Caldés T, de la Hoya M.

Breast Cancer Res Treat. 2011 Oct;129(3):939-46. doi: 10.1007/s10549-011-1543-x.

PMID:
21537932
Items per page

Supplemental Content

Support Center